Clinical trial
Bisphosphonate Treatment of Osteogenesis Imperfecta
NCT00063479 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bisphosphonate Treatment of Osteogenesis Imperfecta
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2003
- Completion date
- May 31, 2007
- Enrollment
- 158
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.